

References
Hayreh SS, Zimmerman MB, Podhajsky P (1994) Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117(4):429–441
Skop BOP, Brown TM (1996) Potential vascular and bleeding complications of treatment with selective seretonin reuptake inhibitors. Psychosomatics 37:12–16
Saur W, Berlin JA, Kimmel SE (2001) Selective seretonin reuptake inhibitors and myocardial infarction. Circulation 104:1894–1898
Stahl SM (1998) Mechanism of action of selective seretonin selective reuptake inhibitors. Seretonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 51:215–235
Kurne A et al (2004) Venous thromboembolism and escitalopram. Gen Hosp Psychiatry 26:481–483
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hardisty, A.D., Hemmerdinger, C.M. & Quah, S.A. Citalopram-associated central retinal vein occlusion. Int Ophthalmol 29, 303–304 (2009). https://doi.org/10.1007/s10792-008-9231-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-008-9231-5